These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9596254)
1. Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery. Moreau P; Takase H; d'Uscio LV; Lüscher TF Stroke; 1998 May; 29(5):1031-5; discussion 1035-6. PubMed ID: 9596254 [TBL] [Abstract][Full Text] [Related]
2. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril. Ledingham JM; Laverty R Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398 [TBL] [Abstract][Full Text] [Related]
3. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. Moreau P; Takase H; Küng CF; van Rooijen MM; Schaffner T; Lüscher TF Stroke; 1995 Oct; 26(10):1922-8; discussion 1928-9. PubMed ID: 7570749 [TBL] [Abstract][Full Text] [Related]
4. [Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?]. Moreau P; Takase H; Küng CF; Lüscher TF Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1141-3. PubMed ID: 8572861 [TBL] [Abstract][Full Text] [Related]
5. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592 [TBL] [Abstract][Full Text] [Related]
6. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887 [TBL] [Abstract][Full Text] [Related]
7. The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat. Lubarsky SL; Ahokas RA; Friedman SA; Sibai BM Am J Obstet Gynecol; 1997 May; 176(5):1069-76. PubMed ID: 9166170 [TBL] [Abstract][Full Text] [Related]
8. Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy. Arribas SM; González C; Graham D; Dominiczak AF; McGrath JC J Hypertens; 1997 Dec; 15(12 Pt 2):1685-93. PubMed ID: 9488223 [TBL] [Abstract][Full Text] [Related]
9. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat. Rumble JR; Komers R; Cooper ME J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape. Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats. Minamino T; Kitakaze M; Papst PJ; Ueda Y; Sakata Y; Asanuma H; Ogai A; Kuzuya T; Terada N; Hori M Cardiovasc Drugs Ther; 2000 Oct; 14(5):533-42. PubMed ID: 11101202 [TBL] [Abstract][Full Text] [Related]
12. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155 [TBL] [Abstract][Full Text] [Related]
13. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996 [TBL] [Abstract][Full Text] [Related]
14. Dietary Zn deficiency does not influence systemic blood pressure and vascular nitric oxide signaling in normotensive rats. Sato M; Kurihara N; Moridaira K; Sakamoto H; Tamura J; Wada O; Yanagisawa H Biol Trace Elem Res; 2003 Feb; 91(2):157-72. PubMed ID: 12719611 [TBL] [Abstract][Full Text] [Related]
15. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats. Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913 [TBL] [Abstract][Full Text] [Related]
16. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat. Clayton JS; Clark KL; Johns EJ; Drew GM Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335 [TBL] [Abstract][Full Text] [Related]
18. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats. Roos CM; Frank DU; Xue C; Johns RA; Rich GF J Appl Physiol (1985); 1996 Jan; 80(1):252-60. PubMed ID: 8847312 [TBL] [Abstract][Full Text] [Related]
19. Structural changes in cerebral arteries following nitric oxide deprivation: a comparison between normotensive and hypertensive rats. Hsieh NK; Wang JY; Liu JC; Lee WH; Chen HI Thromb Haemost; 2004 Jul; 92(1):162-70. PubMed ID: 15213857 [TBL] [Abstract][Full Text] [Related]
20. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism. Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]